Will this be the year Siri becomes board certified?

Share this article:
Nicole ­Johnson is SVP, Director of Digital Strategy at Flashpoint Medica
Nicole ­Johnson is SVP, Director of Digital Strategy at Flashpoint Medica

As a new user of Apple's Siri beta, I can't help but imagine how speech recognition computer software on mobile devices will impact patients, caregivers, healthcare professionals, and ultimately health outcomes. Siri's current claim is “your wish is its command.” Taken further, Siri promises to help you get things done.

Patients, caregivers, and healthcare professionals don't lack in matters that need to get done—or could get done more efficiently. Patients and caregivers are seeking doctors, making appointments, and searching for peer-to-peer community support.  Healthcare professionals are consulting with specialists, checking for drug interactions, managing comorbidities, and at an increasing rate, accessing electronic medical records for their patients. My guess is that most of us would welcome a personal assistant to help out.

To that end, what should our expectations for Siri be? Is there an opportunity for the healthcare industry to come together to define what's needed? Siri's value is accomplished when information seekers retrieve relevant, accurate, and timely data that inform decisions and help drive action.

The healthcare industry is not lacking data and this may be just the opportunity to collaborate, put existing data to good use, and provide guidelines for contributing new data. Siri's first step towards board certification, perhaps a MC (Medical Consult) versus MD, could be creating a health-specific data engine.

The vision for the health data engine would be to identify best-in-class data sources from the industry. The goal is to pool relevant data that could be put to work to help patients, caregivers, and healthcare professionals get the things done that matter most to their health and to providing the best healthcare.

Let's imagine an example of how this might work:

Siri MedConsult: Doctor/Patient Dialog Tool

iPhone User: “Access Jane Smith's record and her diary for the past 30 days.”

Siri: “Ok. Here is Jane's record, diary, and 5 questions to remember to ask Jane during her visit.”

So, even though we're in the early days of Siri, let's start imagining the possibilities together. Early adopters of Siri may already be seeking information that can impact results and improving their health outcomes. Working together across the industry, we can play a role in helping Siri begin the board certification process in 2012, and from there—the possibilities are bright!
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?